Overview

A Trial of Nadolol Plus Isosorbide Mononitrate Versus Carvedilol for the Prevention of Variceal Rebleeding

Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
Carvedilol is shown to be superior to propranolol to reduce the portal pressure. This study was undertaken to compare the effectiveness and complication rates of nadolol and isosorbide mononitrate (ISMN) with carvedilol in the prevention of rebleeding from esophageal varices.
Phase:
Phase 4
Details
Lead Sponsor:
E-DA Hospital
Collaborator:
National Science Council, Taiwan
Treatments:
Carvedilol
Isosorbide
Isosorbide Dinitrate
Isosorbide-5-mononitrate
Nadolol